Scholar Rock - Aset Bersih saben Siji Saham SRRK

Scholar Rock (SRRK) relies on a monolithic staff of R&D experts, minimizing turnover risks through success in clinical trials. A multidisciplinary approach to treating fibrosis, cancer, and muscle atrophy diversifies the development pipeline. This chart of current share prices captures the metric at 2.10. Looking ahead, patent protection for unique drugs will provide the business with pricing power and market dominance.

Scholar Rock, Inc. (SRRK): Nilai Buku Saham saka 04.07.2022 nganti 28.10.2026

scholarrock.com - rincian analitis lan metrik utama (SRRK)

- rega lan prakiraan konsensus rega:

Bagan rega Scholar Rock Corp|SRRK - Konsensus nilai wajar

- data kapitalisasi pasar:

Nilai pasar Scholar Rock Holding Corporation|SRRK - Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Scholar Rock|SRRK - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku scholarrock.com|SRRK - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal Scholar Rock|SRRK - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Scholar Rock Holding Corporation|SRRK - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Scholar Rock Holding Corporation

Pambiji fundamental perusahaan:Scholar Rock Corp - SRRK

Produk sing diprodhuksi Scholar Rock Holding Corporation

An investment audit of the issuer requires a thorough analysis of its capital stability prior to asset acquisition. This metric is calculated as the difference between total assets and all liabilities, divided by the number of shares. For Scholar Rock (SRRK), this serves as a measure of financial reserves amidst fierce competition with gene therapy behemoths. The trend in book value per share under IFRS demonstrates the efficiency of resource accumulation. This indicator determines the real value of an investor's stake, excluding market speculation.

Pesaing Scholar Rock (SRRK)